These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25999169)

  • 21. Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome.
    Kalanadhabhatta V; Muppidi D; Sahni H; Robles A; Kramer M
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):394-400. PubMed ID: 8933778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug eruptions in HIV infection].
    Roujeau JC
    Presse Med; 1994 Jan; 23(3):111-2. PubMed ID: 8177841
    [No Abstract]   [Full Text] [Related]  

  • 23. Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis despite highly active antiretroviral therapy.
    Mammen-Tobin A; Monteiro EF
    Int J STD AIDS; 2000 Jan; 11(1):64-5. PubMed ID: 10667904
    [No Abstract]   [Full Text] [Related]  

  • 24. The acquired immunodeficiency syndrome and a trimethoprim-sulfamethoxazole adverse reaction.
    Cohn DL; Penley KA; Judson FN; Kirkpatrick CH; Horsburgh CR; Davis KC
    Ann Intern Med; 1984 Feb; 100(2):311. PubMed ID: 6607009
    [No Abstract]   [Full Text] [Related]  

  • 25. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.
    White MV; Haddad ZH; Brunner E; Sainz C
    Ann Allergy; 1989 Mar; 62(3):177-9. PubMed ID: 2522290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of Pneumocystis carinii pneumonia relapse in AIDS patients. The efficacy and tolerability of low-dose sulfamethoxazole-trimethoprim.
    Nielsen TL; Jensen BN; Nelsing S; Pedersen C; Mathiesen LR; Skinhøj P; Nielsen JO
    Dan Med Bull; 1993 Sep; 40(4):503-5. PubMed ID: 8222772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS.
    JAMA; 1988 Aug; 260(7):921-2. PubMed ID: 3260965
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute delirium induced by intravenous trimethoprim-sulfamethoxazole therapy in a patient with the acquired immunodeficiency syndrome.
    Salkind AR
    Hum Exp Toxicol; 2000 Feb; 19(2):149-51. PubMed ID: 10773846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV: prevention of opportunistic infections.
    Ioannidis J; Wilkinson D
    Clin Evid; 2005 Jun; (13):834-53. PubMed ID: 16135281
    [No Abstract]   [Full Text] [Related]  

  • 31.
    Zakrzewska M; Roszkowska R; Zakrzewski M; Maciorkowska E
    Dev Period Med; 2019 Oct; 23(3):159-162. PubMed ID: 33759428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sulfamethoxazole-trimethoprim-induced pneumonitis in a patient with hemophilia B who was infected with the human immunodeficiency virus].
    Yamagishi T; Yoshida S; Fukutake K; Utsumi K; Ichinose Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):822-8. PubMed ID: 8810766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients.
    Thomas M; Rupali P; Woodhouse A; Ellis-Pegler R
    Scand J Infect Dis; 2009; 41(11-12):862-8. PubMed ID: 19922070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemoprophylaxis for Pneumocystis carinii pneumonia.
    Colebunders R; Denolf D; Verdonck K
    Pediatr Infect Dis J; 1999 Jul; 18(7):662. PubMed ID: 10440453
    [No Abstract]   [Full Text] [Related]  

  • 35. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
    Hardy WD; Feinberg J; Finkelstein DM; Power ME; He W; Kaczka C; Frame PT; Holmes M; Waskin H; Fass RJ
    N Engl J Med; 1992 Dec; 327(26):1842-8. PubMed ID: 1448121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients.
    Jung AC; Paauw DS
    Arch Intern Med; 1994 Nov; 154(21):2402-6. PubMed ID: 7979835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hypersensitivity cross-reaction with dapsone and cotrimoxazole in a patient infected by the human immunodeficiency virus].
    Jiménez-Lozano I; Alcalde M; Campany Herrero D; Monterde J
    Farm Hosp; 2013; 37(4):335-6. PubMed ID: 24010695
    [No Abstract]   [Full Text] [Related]  

  • 38. Current report--HIV. Recommendations for treatment of acute Pneumocystis carinii pneumonia.
    Goldschmidt RH
    J Am Board Fam Pract; 1991; 4(1):58-60. PubMed ID: 1996514
    [No Abstract]   [Full Text] [Related]  

  • 39. Pneumatoceles in pneumocystic carinii pneumonia of AIDS and low dose trimethoprim-sulphamethoxazole therapy.
    Rosha D; Dandona PK
    J Assoc Physicians India; 1995 Sep; 43(9):635-7. PubMed ID: 8773069
    [No Abstract]   [Full Text] [Related]  

  • 40. Prolonged isolated fever due to attenuated extracerebral toxoplasmosis in patients infected with human immunodeficiency virus who are receiving trimethoprim-sulfamethoxazole as prophylaxis.
    Zylberberg H; Robert F; Le Gal FA; Dupouy-Camet J; Zylberberg L; Viard JP
    Clin Infect Dis; 1995 Sep; 21(3):680-1. PubMed ID: 8527569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.